Global Health Forum Announced to Drive Innovation for an Equitable Healthcare Future
Spearheaded by Dr. Achintya Moulick ,CEO of CarePoint Health, Dr. Samin Sharma, Head of Cardiology at Mt. Sinai, and Mr. Sanat Chattopadhyay Executive Vice President, and President of Merck Manufacturing Division, this initiative is designed to make a transformative impact. Headquartered in Manhattan, NY and will soon establish offices in London, UK and Mumbai, India.
A strategic approach towards Global Healthcare Transformation
Non-Profit Wing: Dedicated to improving healthcare access for underprivileged communities in the India-US corridor, this entity will drive six key agendas (detailed at www.globalhealth-congress.org). The inaugural Global Congress will take place in the NY/NJ region in November 2025 and will bring together leading physicians, pharma and health-tech leaders, hospitals, and industry experts to drive actionable change. More details can be found at www.globalhealthcongress.com.Supporting Healthcare Innovation : Enabled through a proprietary digital platform, this entity 'Venture Vault' will bring together top industry leaders from diverse sectors to promote healthcare innovations, connect leaders across healthcare verticals, and fund and mentor high-growth, high-potential companies committed to advancing healthcare.
Leaders Speak: A Vision for Healthcare Innovation and Equity
Dr. Achintya Moulick, a career CEO and Cardiac Surgeon, emphasized the urgent need for a collaborative approach: "Healthcare innovation must be inclusive. Our initiative will bridge the gaps between research, technology, and accessibility, ensuring a healthier future for all—especially those who have been left behind."
Dr. Samin Sharma, Director of Interventional Cardiology at Mount Sinai Health System, highlighted the vision behind the for-profit wing:"By bringing together leaders from various industries, our digital platform will not only fund cutting-edge healthcare solutions but also mentor and scale ventures that can transform the way healthcare is delivered worldwide."
Mr. Sanat Chattopadhyay, Executive Vice President, and President of Merck Manufacturing, underscored the initiative's global potential:"This is more than just an initiative—it's a movement towards a sustainable and equitable healthcare system. Our Global Congress will serve as a catalyst for meaningful conversations and real-world solutions."
A Call to Action
With the Global Congress Conference in November and the investment platform launching soon, the Global Health Forum and Congress invites healthcare leaders, innovators, investors, and policymakers to join this movement.
For more information, visit:Non-Profit Initiative: www.globalhealth-congress.orgGlobal Health Congress Conference: www.globalhealthcongress.com
For media inquiries and partnerships, contact:Gautam BazazPhone:646.790.4600Email: gautam@globalhealth-congress.org303-5 th Avenue, Suite 1007New York, NY 10016
CONTACT: Gautam Bazaz gautam (at) globalhealth-congress.orgSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
2 hours ago
- Business Upturn
Sacred Journey Recovery in Vista, CA Offers a Life-Changing Approach to Men's Addiction Treatment Amid Rising Meth and Fentanyl Use
Vista, Aug. 01, 2025 (GLOBE NEWSWIRE) — As San Diego County battles a growing surge in methamphetamine and fentanyl use, Sacred Journey Recovery in Vista, California, is offering a transformative solution for men seeking lasting recovery. This innovative men-only treatment center has emerged as a beacon of hope in a region that has seen a troubling rise in overdose deaths and treatment admissions tied to stimulant and opioid abuse. Recent trends show that meth and fentanyl, often used together, are driving up emergency room visits and contributing to a new wave of addiction that traditional models of rehab are struggling to address. Sacred Journey Recovery stands apart by combining clinical excellence with adventure-based healing and a uniquely masculine, purpose-driven culture. The program's foundation is built on an integrated clinical model that utilizes evidence-based therapies including Dialectical Behavioral Therapy, Cognitive Behavioral Therapy, Acceptance and Commitment Therapy, and Narrative Therapy. These modalities go beyond surface-level coping strategies and reach into the core of what fuels addiction. DBT helps men gain control over impulsive behaviors and intense emotional swings. CBT rewires distorted beliefs and habits that perpetuate substance use. ACT teaches clients how to move through pain while still acting in alignment with their personal values, and Narrative Therapy gives men the chance to redefine their identity through a more empowered lens. These methods are not simply confined to the therapy room. They are actively lived out—on hiking trails, climbing walls, and in deep fireside conversations that foster trust and growth. What truly elevates the experience at Sacred Journey Recovery is its use of cutting-edge brain mapping technology, or QEEG. This non-invasive diagnostic tool captures a snapshot of the brain's electrical activity, offering insights into overactive or under-functioning regions that may be contributing to anxiety, depression, trauma, or cognitive difficulties. By understanding the brain's patterns, clinicians can create highly customized treatment plans while giving clients a visual representation of how their brain is healing throughout the recovery journey. It also serves a larger purpose: reframing addiction as a brain-based disorder rather than a moral failure, which can be a transformative shift for men who have carried deep shame into treatment. The treatment model extends beyond clinical interventions. Sacred Journey Recovery's program is rooted in mentorship, community, and challenge. Clients participate in experiential therapies that include hiking, camping, indoor skydiving, wolf therapy, and structured rites of passage. These experiences are not recreational extras—they are designed to facilitate breakthroughs, cultivate resilience, and foster a sense of earned confidence and brotherhood. In a world where men are often isolated and discouraged from emotional expression, Sacred Journey creates space for connection, self-reflection, and leadership. San Diego County's rising overdose rates, particularly from fentanyl-laced street drugs and methamphetamine, have placed an urgent spotlight on the need for accessible, innovative care. Vista, located in the heart of North County, has become a critical area of focus. Sacred Journey's outpatient model includes both Partial Hospitalization Programs (PHP) and Intensive Outpatient Programs (IOP), providing structured, consistent care while allowing clients to gradually reenter work, family, and community life. The facility also partners with trusted sober living homes, giving clients the stability and support they need during this transitional period. One family member who witnessed the transformation firsthand shared, 'Sacred Journey Recovery is an incredible men's rehab in sunny Vista, CA offering adventure-based PHP and IOP programs. Their team combines clinical care with real-world healing through outdoor wilderness therapy, wolf therapy, brotherhood, and holistic support. Taking their clients hiking, rappelling, camping, indoor skydiving really sets them apart in the recovery space. Their sober living partnerships help clients succeed beyond treatment. Highly recommend for any man who is ready to transform their life.' At a time when men across California are facing overwhelming pressure from addiction, trauma, and disconnection, Sacred Journey Recovery is offering something bold and vital: a place to rediscover strength, reclaim purpose, and build a life worth staying sober for. With clinical integrity, deep brotherhood, and adventure at its core, this Vista-based center is not only changing lives—it's redefining what recovery can be. ### For more information about Sacred Journey Recovery, contact the company here: Sacred Journey RecoveryDrew Anagnostou760-888-5202 [email protected] 161 Thunder Drive #214, Vista, California 92083
Yahoo
6 hours ago
- Yahoo
Medical Tourism Market Size Projected to Expand USD 186.27 Bn at 16.12% CAGR by 2034
The global medical tourism market size is calculated at USD 48.53 billion in 2025 and is expected to reach around USD 186.27 billion by 2034, growing at a CAGR of 16.12% for the forecasted period. Ottawa, Aug. 01, 2025 (GLOBE NEWSWIRE) -- The global medical tourism market size was valued at USD 41.79 billion in 2024 and is predicted to hit around USD 186.27 billion by 2034, a study published by Towards Healthcare a sister firm of Precedence Research. The growth of the market is driven by the rising demand from the consumers as well as the government to improve easy accessibility and for the treatment of patients with all the facilities and proper treatment, which increases the growth. Access comprehensive market data, historical figures and future projections in an easy-to-analyze format: Key Takeaways North America dominated the medical tourism market in 2024. Asia Pacific is estimated to be the fastest-growing region during the forecast period. By treatment type, the cosmetic segment held the largest share of the market in 2024. By treatment type, the infertility segment is estimated to grow at the fastest CAGR during the forecast period. By service provider, the private segment held the major share of the market and is estimated to grow at the fastest rate during 2025-2034. Medical Tourism Market Overview & Potential Medical tourism involves traveling abroad for medical treatment, often driven by lower costs or access to specialized care unavailable locally. It is also called medical travel, health tourism, or global healthcare. India is becoming a favored destination, offering high-quality treatment, health and wellness services, and affordability. Key Metrics and Overview Metric Details Market Size in 2024 USD 41.79 Billion Projected Market Size in 2034 USD 186.27 Billion CAGR (2025 - 2034) 16.12% Leading Region North America Market Segmentation By Treatment Type, By Service Provider, By Region Top Key Players MOHW Hengchun Tourism Hospital, Apollo Hospitals Enterprise Ltd., Bumrungrad International Hospital, Mount Elizabeth Hospitals, Raffles Medical Group, Dr. B. L. Kapur Memorial Hospital, Kasemrad Hospital International Rattanathibet, Mission Hospital, Bangkok Hospital, Miot Hospital, Penang Adventist Hospital What Are the Key Growth Drivers Responsible for The Growth of The Medical Tourism Market? The market's expansion is mainly fueled by the high healthcare costs in developed countries, alongside the availability of advanced and affordable treatments elsewhere. Additional factors include increasing demand for non-insured or specialized procedures such as cosmetic or gender reassignment surgeries, as well as the rising elderly and uninsured populations. The growing number of seniors and those without sufficient health insurance in developed nations also boosts medical tourism. What Are the Emerging Trends in The Medical Tourism Market? Cost Savings: Countries like India, Thailand, and Singapore offer treatment at significantly lower prices compared to developed nations, attracting more tourists. Advanced Medical Technologies: Many nations provide state-of-the-art equipment, innovative treatments, and specialized procedures that may be less accessible or affordable at home. Wellness Tourism: Growing interest in wellness services, including cosmetic and reproductive therapies, contributes to the market rise. Aging Populations: Older populations in developed countries face higher healthcare costs, prompting more people to seek affordable options abroad. Rising Healthcare Expenses: The escalating cost of healthcare in countries like the US and the UK is a key factor driving medical tourism. You can place an order or ask any questions, please feel free to contact us at sales@ What Are the Key Challenges That Hinder the Growth of The Medical Tourism Market? The industry encounters several hurdles, such as inconsistent healthcare quality, regulatory issues, language barriers, and ethical concerns. These challenges can influence patient safety, satisfaction, and the success of destination countries. Navigating foreign legal and regulatory systems can be complex, especially when complications or disputes arise. Additionally, language differences and cultural nuances may impede effective communication between patients and providers, increasing the risk of misunderstandings and errors. Regional Analysis How Did North America Dominate the Medical Tourism Market in 2024? North America dominated the medical tourism market in 2024. The growth of the market is driven by significant aspects of aesthetic tastes, beauty standards, and lifestyle choices, leading to a strong demand for elective and cosmetic procedures. To access affordable and high-quality care abroad, patients seeking dental work, reproductive treatments, cosmetic surgery, or weight reduction surgery often choose medical tourism. Patients looking for elective procedures or aesthetic enhancements are attracted to medical tourism destinations because they offer comprehensive cosmetic packages, state-of-the-art facilities, and experienced doctors. With one of the best healthcare systems in the region, these destinations promise medical tourists advanced, high-quality services often at a fraction of the cost compared to other industrialized nations. The U.S. is witnessing rising inbound medical tourism due to its advanced healthcare technologies and specialized treatments, especially in areas like cardiac surgery and cancer care. Patients from the Middle East and the Caribbean often seek second opinions or procedures unavailable in their countries. The Cleveland Clinic and the Mayo Clinic are top destinations. Canada's universal healthcare system and high medical standards attract tourists from the U.S. and the Caribbean, primarily for procedures like orthopedic surgery and diagnostics. Cities like Toronto and Vancouver are preferred due to multilingual support and low complication rates. Wait times for citizens also drive outbound medical travel to nearby countries. Get the latest insights on life science industry segmentation with our Annual Membership: What Made the Asia Pacific Significantly Grow in The Medical Tourism Market In 2024? Asia Pacific is estimated to be the fastest-growing region during the forecast period. The growth is fueled by several factors that make the area a popular choice for medical treatment. Cost savings are a primary motivator, as healthcare in countries like Malaysia, Thailand, and India is significantly less expensive than in Western nations without compromising quality. The region also boasts top-tier healthcare facilities accredited by international organizations and highly skilled medical professionals. Its appeal is further enhanced by cutting-edge medical treatments and technology, as well as shorter wait times for procedures. Government programs and regulations that boost revenue from the medical tourism industry, such as expedited visa procedures and marketing efforts, also play a crucial role in the growth and expansion of the market in the region. China's rise in medical tourism is driven by its integration of traditional Chinese medicine (TCM) with modern treatments, drawing patients from Southeast Asia and Russia. Cosmetic surgery, fertility treatments, and oncology are popular. Hospitals in Beijing and Shanghai often offer multilingual services and high-end packages tailored to international patients' needs. India is a top medical tourism hub due to affordable yet high-quality care, especially in cardiology, orthopedics, and transplant surgery. English-speaking doctors and internationally accredited hospitals attract patients from Africa, the Middle East, and South Asia. Cities like Chennai and Delhi lead, with holistic care options including Ayurveda and yoga. Segmental Insights By treatment type, The cosmetic segment held the largest share of the market in 2024. Cosmetic Treatment Cosmetic treatment is a major driver of the medical tourism market, with patients traveling abroad to access affordable, high-quality aesthetic procedures. Commonly sought treatments include rhinoplasty, liposuction, facelifts, breast augmentation, and hair restoration. Many choose destinations known for skilled surgeons, modern infrastructure, and shorter waiting times. Countries in Asia, Eastern Europe, and Latin America are popular for their cost-effective yet advanced cosmetic services. The growing desire for appearance enhancement, combined with the availability of luxury recovery packages and post-surgical care, continues to boost international demand. However, concerns regarding regulatory standards and follow-up care remain important considerations for travelers. The infertility segment is estimated to grow at the fastest CAGR during the forecast period. Infertility treatment is a significant segment of the medical tourism market, attracting individuals and couples seeking advanced reproductive care at affordable prices. Treatments commonly include in vitro fertilization (IVF), intrauterine insemination (IUI), egg and sperm donation, and surrogacy services. Patients often travel to countries with favorable legal frameworks, high success rates, and shorter waiting periods. Medical tourists are drawn to internationally accredited fertility clinics that offer personalized care, cutting-edge technologies, and bundled treatment packages. Emotional sensitivity, ethical considerations, and varying regulations across countries play a crucial role in influencing destination choices within this growing treatment segment. By the service provider The private segment held the major share of the market and is estimated to grow at the fastest rate during 2025-2034. Private service providers dominate the medical tourism market by offering personalized care, shorter waiting times, and access to advanced medical technologies. These providers often collaborate with internationally accredited hospitals, specialized clinics, and luxury recovery centers to cater to foreign patients seeking quality treatment. Competitive pricing, multilingual staff, and tailored treatment packages enhance patient experience and trust. Private healthcare facilities also invest heavily in marketing, digital platforms, and concierge services to attract international clients. Their focus on high standards, comfort, and discretion makes them the preferred choice for medical tourists across treatment types, including cosmetic, dental, orthopedic, and fertility procedures. Recent Developments in the Medical Tourism Market In March 2025, Iran introduced a comprehensive medical tourism management system. Led by the Ministry of Cultural Heritage, Handicrafts, and Tourism, this initiative aims to improve coordination, transparency and efficiency in Iran's expanding health tourism sector. The goal is to develop a robust health tourism industry by enhancing medical facilities and strengthening the country's medical sector. In February 2025, in India, Health Minister Nirmala Sitaraman announced the opening of 200 cancer day care centers. She also stated that the government will promote medical tourism and simplify the visa process through the Heal in India initiative, along with the introduction of 36 drugs for cancer and rare diseases, which will be exempt from basic customs duty. In April 2025, Prataprao Jadhav, Minister of State (IC) for the Ministry of Ayush and Minister of State for the Ministry of Health and Family Welfare, revealed plans to develop a comprehensive online portal for Medical Value Travel (MVT). This portal aims to enhance India's reputation as a global healthcare destination and strengthen its medical sector. Elevate your healthcare strategy with Towards Healthcare. Enhance efficiency and drive better outcomes schedule a call today: Top Companies and Their Contributions to the Market Hospital/Group Contributions & Offerings MOHW Hengchun Tourism Hospital Located in Taiwan, it integrates wellness tourism with local cultural experiences. It offers services like rehabilitation, TCM, and elder care, appealing to Asian tourists. Apollo Hospitals Enterprise Ltd. A pioneer in Indian medical tourism, Apollo offers affordable treatments in cardiology, oncology, and organ transplants, with JCI-accredited facilities across major cities. Bumrungrad International Hospital Based in Thailand, it serves over 520,000 international patients annually. It is known for cutting-edge diagnostics and multilingual staff, especially in heart and cancer care. Mount Elizabeth Hospitals Located in Singapore, it provides complex surgeries and high-end diagnostics. International patients benefit from concierge services and specialist care in cardiology and oncology. Raffles Medical Group Operating across Asia, Raffles offers preventive health checks, general surgery, and chronic disease management. Its seamless cross-border care appeals to regional tourists. Dr. B. L. Kapur Memorial Hospital A leading Indian hospital with strengths in minimally invasive surgery, fertility treatments, and transplant services. It's known for personalized, affordable care. Kasemrad Hospital International Rattanathibet A Thai hospital offering cosmetic surgery, orthopedics, and dental tourism with affordable pricing and international patient support. Mission Hospital Located in Thailand, it specializes in wellness, orthopedics, and dental care, combining spiritual care with modern treatment, drawing faith-based medical tourists. Bangkok Hospital One of Southeast Asia's most advanced hospitals, known for comprehensive specialty centers and advanced tech. It attracts patients from the Middle East and ASEAN. Medical Tourism Market Key Players List MOHW Hengchun Tourism Hospital Apollo Hospitals Enterprise Ltd. Bumrungrad International Hospital Mount Elizabeth Hospitals Raffles Medical Group Dr. B. L. Kapur Memorial Hospital Kasemrad Hospital International Rattanathibet Mission Hospital Bangkok Hospital Miot Hospital Penang Adventist Hospital Global Healthcare Market Insights (2024–2034) Medical Foods for Orphan Diseases MarketThe medical foods for orphan diseases market is gaining momentum as targeted nutritional therapies become essential in rare disease management. Valued at USD 8.84 billion in 2024, the market is expected to reach USD 14.65 billion by 2034, growing at a steady CAGR of 5.2%. AI in Medical Billing MarketThe AI in medical billing market is witnessing explosive growth as healthcare providers turn to automation for improved accuracy and faster reimbursements. Estimated at USD 3.73 billion in 2024, the market is projected to soar to USD 36.37 billion by 2034, registering a CAGR of 25.4%. Automated Medical Coding MarketThe automated medical coding market is rapidly advancing, supported by the integration of AI and machine learning tools. While specific figures are still developing, it's expected to generate hundreds of millions in revenue between 2025 and 2034, as demand for accurate and efficient coding surges. Pain Management Devices MarketDriven by the rise in chronic conditions and minimally invasive treatments, the pain management devices market is forecast to grow from USD 7.68 billion in 2024 to USD 19.1 billion by 2034, at a robust CAGR of 9.54%. Medical Device CRO MarketThe medical device contract research organization (CRO) market is benefiting from increased outsourcing in R&D. With a market size of USD 8.49 billion in 2024, it is anticipated to reach USD 19.9 billion by 2034, expanding at a CAGR of 8.98%. Medical Polymers MarketThe medical polymers market is expanding due to rising applications in implants, devices, and packaging. Valued at USD 23.29 billion in 2024, it's projected to hit USD 50.46 billion by 2034, with a healthy CAGR of 8.04%. Medical Billing MarketThe broader medical billing market (excluding AI-specific billing) continues to grow as providers seek scalable revenue cycle solutions. Starting at USD 17.86 billion in 2024, the market is expected to reach USD 54.93 billion by 2034, growing at a CAGR of 12.17%. Medical Membrane MarketApplications in dialysis, diagnostics, and drug delivery are fueling growth in the medical membrane market. Valued at USD 4.26 billion in 2024, it's set to reach USD 8.74 billion by 2034, reflecting a CAGR of 7.45%. Medical Imaging MarketThe medical imaging market continues to grow steadily due to rising healthcare needs and technological advancements. It's forecasted to increase from USD 41.64 billion in 2024 to USD 67.87 billion by 2034, growing at a CAGR of 4.99%. Wearable Medical Devices MarketThe wearable medical devices market is seeing exceptional adoption, especially for remote monitoring and fitness applications. Starting at USD 42.78 billion in 2024, it's projected to surge to USD 408.61 billion by 2034, expanding at an impressive CAGR of 25.57%. Segments Covered in The Report By Treatment Type Cardiovascular treatment Orthopedic treatment Cosmetic treatment Bariatric treatment Dental treatment Ophthalmology treatment Infertility treatment Alternative medicine Other services By Service Provider Public Private By Region North America U.S. Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait To invest in our premium strategic solution and customized market report options, click here: You can place an order or ask any questions, please feel free to contact us at sales@ Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire Find us on social platforms: LinkedIn | Twitter | Instagram
Yahoo
6 hours ago
- Yahoo
Gynecological Devices Market Size to Surpass USD 23.22 Billion by 2034 Driven by AI, Robotics and Minimally Invasive Surgeries
The global gynecological devices market size is expected to surpass USD 23.22 billion by 2034 increasing from USD 11.38 billion in 2025. The market is expected to grow at a CAGR of 8.25% from 2025 to 2034, fueled by groundbreaking innovations in AI-powered diagnostics and robotic-assisted surgeries. With women's health taking center stage in global healthcare policies, the industry is witnessing a rapid transformation. Ottawa, Aug. 01, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the global gynecological devices market was valued at USD 10.52 billion in 2024, grew to USD 11.38 billion in 2025 and is and is predicted to rise from USD 12.31 billion in 2026 to approximately USD 23.22 billion by 2034. In terms of CAGR, the market is poised to grow at a solid CAGR of 8.25% from 2025 to 2034. The growing awareness of women's health and the increasing prevalence of gynecological disorders drive the market growth. Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.➡️ Try Before You Buy – Get the Sample Report@ Quick Insight: Gynecological Devices Market Key Takeaways In terms of revenue, the global gynecological devices market was evaluated at USD 10.52 billion in 2024. It is projected to exceed USD 23.22 billion by 2034. It is expected to expand at a CAGR of 8.25% from 2025 to 2034. North America accounted for the highest market share of 41.82% in 2024. Asia Pacific is poised to grow at the fastest CAGR of 8.64% between 2025 and 2034. By product, the surgical devices segment contributed the largest market share of 53.20% in 2024. By product, the handheld instruments segment is forecast to grow at a CAGR of 8.4% from 2025 to 2034. By end-use, the hospitals and clinics segment dominated in 2024 with a 65.26% market share. By end-use, the ambulatory surgery centers (ASCs) segment is expected to register a CAGR of 8.1% through 2034. Gynecological Devices Market Revenue Analysis from 2022 to 2024 (USD Million) Gynecological Devices Market Revenue (USD Million) By Product 2022-2024 By Product 2022 2023 2024 Surgical Devices 4,794.93 5,178.60 5,598.2 Handheld Instruments 1,299.72 1,404.02 1,518.1 Diagnostic Imaging Systems 2,935.35 3,160.75 3,406.6 Gynecological Devices Market Revenue (USD Million) By End-Use 2022-2024 By End-Use 2022 2023 2024 Hospital & Clinics 5,883.95 6,353.65 6,867.2 Ambulatory Surgery Centers (ASCs) 3,146.05 3,389.72 3,655.6 Get instant access to in-depth market forecasts, competitive analysis, and growth opportunities in the gynecological devices space. ➡️ Buy the Full Report Now | ✚ sales@ | ☎ +1 804 441 9344 Gynecological Devices Market Overview What is a Gynecological Device? Gynecological devices are medical instruments used to manage, diagnose, & treat various female reproductive system conditions. These devices enhance visualization, increase dexterity, and minimize tissue trauma. Gynecological devices are widely used by gynecologists to treat various gynecological conditions like pelvic floor disorders, endometriosis, and uterine fibroids. The gynecological devices consist of diagnostic tools, surgical instruments, and other devices. The diagnostic tools include colposcopes, biopsy tools, endometrial ablation devices, speculums, ultrasound probes, and hysteroscopes. The surgical instruments include dilators, resectoscopes, amnioscopes, forceps, curettes, clamps, and fetoscopes. The other devices are contraceptive devices, postpartum hemorrhage control devices, fetal monitors, and endometrial ablation devices. We're seeing a global push toward early gynecological diagnosis and robotic-assisted treatments, especially in urban healthcare systems,' said Rohan Patil, Principal Consultant at Precedence Research. ➤ Gynecological Devices Exports' Data & Statistics: Who are the Leading Exporters of the Hysteroscope? Country Exports Germany 569 Shipments Mexico 464 Shipments United States 138 Shipments Who are the Leading Exporters of the Vaginal Speculum? Country Exports China 857 Shipments Germany 767 Shipments Gynecological Devices Market Latest Trends 1. Rise of Minimally Invasive and Office-Based Procedures There's a growing preference for gynecological devices that support minimally invasive procedures such as laparoscopic surgeries, endometrial ablation, and hysteroscopic diagnostics. These devices allow faster recovery, less post-op pain, and shorter hospital stays. Additionally, the shift toward office-based gynecological interventions is increasing demand for portable and single-use devices. 2. Increased Use of Robotic-Assisted Surgery Hospitals and surgical centers are investing in robotic platforms for gynecological procedures, particularly hysterectomies and myomectomies. These systems provide enhanced precision, better visualization, and reduced complications, making them a preferred choice for complex surgeries, especially in urban and high-resource settings. 3. Growth in Smart Diagnostic Tools Artificial intelligence and smart imaging systems are being integrated into diagnostic tools to improve accuracy in detecting fibroids, ovarian cysts, endometriosis, and cervical abnormalities. Smart colposcopes and AI-powered diagnostic imaging are making early detection more efficient and accessible. 4. Focus on Pelvic Health and Postpartum Devices There is increased innovation in devices aimed at postpartum recovery, urinary incontinence, and pelvic organ prolapse treatment. These include electrical stimulation devices, pessaries, and laser-based therapies. Demand is growing in both aging populations and among postpartum women in developed and emerging markets. 5. Patient-Centric, At-Home Monitoring Devices Consumers are increasingly using at-home fertility monitors, menstrual tracking devices, and hormone testing kits. These products empower patients to monitor their reproductive health and reduce dependency on clinic visits, supporting the broader trend toward personalized and preventive care. Gynecological Devices Market Opportunity What is the Opportunity for the Gynecological Devices Market? The Growing Prevalence of Gynecological Disorders The growing prevalence of various gynecological disorders like endometriosis, cervical cancer, uterine fibroids, and ovarian cysts increases demand for gynecological devices for effective treatment. The increasing focus on early detection of gynecological disorders increases demand for devices like hysteroscopes and colposcopes. The rapid growth in age-related gynecological disorders leads to a higher demand for gynecological devices. The increasing focus on early diagnosis and awareness about women's health fuels demand for gynecological devices. The trend of minimally invasive surgical procedures increases demand for specialized gynecological devices. The devices provide benefits like improving patient outcomes, lowering recovery time, and minimal scarring. The technological advancements like robotic surgery, 3D imaging, and portable diagnostic tools help the market growth. The growing prevalence of gynecological disorders creates an opportunity for the gynecological devices market. Limitations and Challenges in the Gynaecological Devices Market What is the Limitation for the Gynecological Devices Market? ✚ High Production Cost Shuts Down Expansion of Gynecological Devices Despite several benefits of the gynecological devices, the high production cost restricts the market growth. Factors like complex manufacturing, stringent regulations, need for specialized materials, complex designs, specialized components, and high R&D costs are responsible for high production costs. The complex designs of gynecological devices are due to factors like minimally invasive procedures increase the cost. The need for accuracy in assembly and components increases the production cost. The need for raw materials like specialized metals and biocompatible polymers increases the cost. The growing investment in R&D directly affects the market. The stricter regulatory compliance, like EMA and FDA, fuels the manufacturing cost. The complex manufacturing processes like specialized coatings, laser cutting, and 3D printing require high cost. The high production cost hampers the growth of the gynecological devices market. ✚ Regulatory Inequality Across Countries The lack of regulatory harmonization between developed and developing nations poses a significant challenge for manufacturers. Companies must navigate differing approval processes, certification standards, and product registration protocols in each region. This creates delays in product launches and increases operational complexity, especially for startups and SMEs aiming for global expansion. ✚ Training Shortages in Developing Markets Despite the availability of advanced gynecological technologies, many low- and middle-income countries lack skilled professionals trained in minimally invasive procedures or the use of robotic-assisted devices. This limits the effective adoption of new tools and reduces patient outcomes in resource-limited settings. Bridging the training gap is essential to ensure equitable access to modern gynecological care. Gynecological Devices Market Report Coverage Report Attributes Statistics Growth Rate (2025 to 2034) CAGR of 8.25% Market Size in 2024 USD 10.52 Billion Market Size in 2025 USD 11.38 Billion Market Size in 2030 USD 17.03 Billion Market Size in 2032 USD 20.14 Billion Market Size by 2034 USD 23.22 Billion Base Year 2024 Forecast Period 2025 to 2034 Prominent Region in 2024 North America (captured 41.82% market share) Fastest Growing Region (2025-2034) Asia Pacific (8.64% CAGR) Segments Covered Product, End Use, and Region Regions Covered North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Key Market Drivers Rising prevalence of gynecological disorders, increased adoption of minimally invasive procedures Key Restraints High cost of advanced devices, limited access in underdeveloped regions Opportunities Technological advancements, increasing healthcare investments in emerging economies Technology Trends Integration of robotics and AI in surgical devices, telemedicine for diagnostics Regulatory Trends Increased scrutiny by FDA and EMA, rising importance of device certifications Recent Developments Product launches in robotic-assisted gynecologic surgeries and imaging technologies Top Companies Boston Scientific Corporation, Ethicon Inc., Karl Storz Gmbh & Co. KG, Cooper Surgical Inc., Hologic Inc., Medtronic plc, Olympus Corporation, Stryker Corporation, Richard Wolf GmbH, MedGyn Product Inc. and others Become a valued research partner with us - Gynecological Devices Market Key Regional Insights How North America Dominates the Gynecological Devices Market? North America dominated the gynecological devices market in 2024. The strong presence of healthcare infrastructure, like specialized facilities, hospitals, and clinics, increases demand for gynecological devices. The growing early diagnosis of women's health issues and awareness about women's health help the market growth. The growing female population and increasing need for gynecological care increase demand for gynecological devices. The growing investment in R&D in advanced imaging systems & robotic-assisted surgery fuels demand for gynecological devices. The favorable reimbursement policies and presence of key players drive the market growth. U.S. Gynecological Devices Market Size and Forecast 2025 to 2034 How Big is the U.S. Gynecological Devices Market? According to Precedence Research, The U.S. gynecological devices market size is valued at USD 4.17 billion in 2025 and is projected to grow from USD 4.89 billion in 2026 and is expected to hit around USD 8.53 billion by 2034, growing at a CAGR of 8.29% from 2025 to 2034. Download your free sample, schedule a custom market briefing, or explore our subscription plans to stay ahead in the women's health devices market. ➡️ | ✚ sales@ | ☎ +1 804 441 9344 Which Region is the Fastest-Growing in the Gynecological Devices Market? Asia Pacific is experiencing the fastest growth in the market during the forecast period. The growing prevalence of gynecological disorders like pelvic floor disorders, endometriosis, and uterine fibroids increases demand for gynecological devices. The growth in age-related gynecological conditions helps the market growth. The growing investment in the healthcare infrastructure increases demand for gynecological devices. The shift towards minimally invasive procedures and expansion of healthcare facilities fuels demand for gynecological devices. The strong government support for women's health supports the overall growth of the market. Top Countries & Their Key Drivers in Gynecological Devices Market: The United States leads the gynecological devices market with advanced healthcare infrastructure, high adoption of minimally invasive technologies, and strong investment in women's health innovation. Canada follows closely with its emphasis on public health initiatives and increasing surgical device adoption in outpatient gynecology settings. In India, rapid urbanization, rising awareness of reproductive health, and government support for maternal care are fueling demand for diagnostic and therapeutic gynecological devices, especially in tier 2 and tier 3 cities. Meanwhile, Japan is witnessing steady market growth driven by its aging female population, early adoption of robotic-assisted surgeries, and a strong focus on preventive gynecological screening through national health programs. Gynaecological Devices Market Segmentation Analysis: Product Analysis: The surgical devices segment dominated the gynaecological market in 2024. The growing number of surgeries, like abnormal uterine bleeding, uterine fibroids, and endometriosis, increases demand for surgical devices. The focus on minimally invasive procedures like hysteroscopy and laproscopy helps the market growth. The rise in gynecological surgeries like sterilization surgeries, hysterectomies, and fibroid removals increases demand for surgical devices. The ongoing technological advancements, like robotic surgery and improved imaging, drive the market growth. The diagnostic imaging systems segment is the fastest-growing in the market during the forecast period. The increasing prevalence of various gynecological issues increases demand for diagnostic imaging systems. The presence of imaging technologies like hysteroscopy, Magnetic Resonance Imaging Market (MR), and ultrasound helps the market growth. The focus on accurate diagnosis and growth in routine gynecological check-ups increases demand for diagnostic imaging systems. The increasing adoption of remote imaging technologies and advancements in technologies like the integration of artificial intelligence (AI), 3D/4D ultrasound, and enhanced image resolution support the market growth. End Use Analysis: The hospital & clinics segment held the largest revenue share in the gynecological devices market. The availability of various gynecological services like surgical procedures, diagnostic testing, treatment, and preventive care increases the adoption of hospitals & clinics. The presence of advanced therapeutics equipment and diagnostic equipment in hospitals & clinics helps the market growth. The large number of skilled professionals, like nurses, gynecologists, and other professionals, and the presence of advanced facilities drive the market growth. The ambulatory surgery centers (ASCs) segment is experiencing the fastest growth in the market during the forecast period. The increasing preference for minimally invasive gynecological surgeries like laparoscopy increases demand for ambulatory surgery centers. The focus on minimizing medical bills and lowering recovery times increases the adoption of ASCs. The growing gynecological issues like ovarian cysts, fibroids, and endometriosis fuel demand for ASCs. The focus on outpatient care and streamlining patient experiences supports the overall market growth. Case Study Spotlight: Personalized Gynecological Devices in Action Source: In June 2025, Cosm Medical, a Toronto-based medical startup, secured Seed+ financing led by iGan Partners to scale its AI-driven platform for personalized vaginal devices. The platform uses a combination of 3D printing, medical imaging, and artificial intelligence to custom design vaginal pessaries tailored to individual pelvic anatomies. These devices are transforming treatment for pelvic floor disorders, offering better fit, comfort, and outcomes—especially for postpartum women and the elderly. According to Cosm Medical, traditional pessaries often lack comfort and customization, resulting in discontinuation. Their AI-integrated solution not only improves adoption rates but also enables digital tracking for long-term care plans. This case demonstrates how AI and 3D printing are not just trends—but real, scalable innovations redefining gynecological care. Ready to Explore the Future of Women's Health? ➡️ Download your FREE sample report: ☎ Schedule a Personalized Market Briefing: ☎ Contact Us:Email: | Phone: +1 804 441 9344 Related Topics You May Find Useful: ➢ Women's Health Devices Market: The global women's health devices market size was valued at USD 36.26 billion in 2024 and is expected to reach over USD 82.03 billion by 2034 with a registered CAGR of 8.51% from 2025 to 2034. ➢ General Surgery Devices Market: The global general surgery devices market size accounted for USD 15.33 billion in 2024 and is expected to exceed USD 34.63 billion by 2034, growing at a CAGR of 8.49% from 2025 to 2034. ➢ Ultrasound Devices Market: The global ultrasound devices market size accounted for USD 12.34 billion in 2024 and is expected to reach around USD 27.37 billion by 2034, expanding at a CAGR of 8.29% from 2025 to 2034. ➢ Intrauterine Devices Market: The global intrauterine devices market size was calculated at USD 6.48 billion in 2024 and is anticipated to reach around USD 9.29 billion by 2034, growing at a CAGR of 3.67% over the forecast period 2025 to 2034. ➢ Ablation Devices Market: The global ablation devices market size accounted for USD 9.90 billion in 2024 and is predicted to increase from USD 10.84 billion in 2025 to approximately USD 24.62 billion by 2034, expanding at a CAGR of 9.54% from 2025 to 2034. ➢ Electrosurgical Devices Market: The global electrosurgical devices market size accounted for USD 7.15 billion in 2024 and is anticipated to reach around USD 9.78 billion by 2034, growing at a CAGR of 3.54% from 2025 to 2034. ➢ Surgical Equipment Market: The global surgical equipment market size was recorded at USD 18.52 billion in 2024 and is anticipated to be worth around USD 20.30 billion by 2025, expecting at a CAGR of 9.60% from 2025 to 2034. ➢ Breast Biopsy Devices Market: The global breast biopsy devices market size was estimated at USD 1.09 billion in 2024 and is expected to reach around USD 1.64 billion by 2034, growing at a CAGR of 4.17% from 2025 to 2034. ➢ Portable Medical Devices Market: The global portable medical devices market size was estimated at USD 69.30 billion in 2024 and is anticipated to reach around USD 202.52 billion by 2034, expanding at a CAGR of 11.32% from 2025 to 2034. Gynaecological Devices Market Key Companies Boston Scientific Corporation Ethicon Inc. Karl Storz Gmbh & Co. KG Cooper Surgical Inc. Hologic Inc. Medtronic plc Olympus Corporation Stryker Corporation Richard Wolf GmbH MedGyn Product Inc. Recent Developments: In April 2025, Womed launched a female fertility preserving device, Womed Leaf, in Europe. The device is made up of a flexible, soft film and is inserted like an IUD. The device is available in Germany, Denmark, Finland, Switzerland, France, Sweden, Norway, and Austria. (Source: In June 2025, iGan Partners leads Seed+ Financing for Cosm Medical to advance personalised gynecological devices. The platform combines 3D printing, medical imaging, and AI-driven design software to develop custom vaginal devices. The solution addresses pelvic floor disorders and offers better care for women. (Source: Gynecological Devices Market Segmentation Covered in the Report By Product Surgical Devices Gynecological Imaging Devices Portable Tools By End Use Hospital & Clinics Ambulatory Surgery Centers (ASCs) By Region North America U.S. Canada Europe Germany UK France Italy Spain Sweden Denmark Norway Asia Pacific China Japan India South Korea Thailand Latin America Brazil Mexico Argentina Middle East & Africa South Africa UAE Saudi Arabia Kuwait Thank you for reading. You can also get individual chapter-wise sections or region-wise report versions, such as Immediate Delivery Available | Buy This Premium Research Report@ You can place an order or ask any questions, please feel free to contact at sales@ | +1 804 441 9344 Stay Ahead with Precedence Research Subscriptions Unlock exclusive access to powerful market intelligence, real-time data, and forward-looking insights, tailored to your business. From trend tracking to competitive analysis, our subscription plans keep you informed, agile, and ahead of the curve. Browse Our Subscription Plans@ About Us Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally. Web: Our Trusted Data Partners: Towards Healthcare | Towards Packaging | Towards Automotive | Towards Chem and Materials | Towards FnB | Towards Consumer Goods | Statifacts | Towards EV Solutions | Towards Dental | Nova One Advisor Get Recent News: For the Latest Update Follow Us: LinkedIn | Facebook | TwitterError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
